Myeloid Expands Leadership Team with Robert Hofmeister, Ph.D., as Chief Scientific Officer
Position
Chief Scientific Officer
Company
Myeloid
United StatesBiotechnologyHealth CareMedicalTherapeuticsDescription
Myeloid Therapeutics, Inc has appointed Robert Hofmeister as Chief Scientific Officer (CSO). Dr Hofmeister brings more than 25 years of scientific leadership experience and a track record of drug discovery and early development. He will lead the expansion of Myeloid's cutting-edge RNA focused research and development efforts, aimed at designing novel therapeutics that target, deliver, and program immune cells to combat cancer and other deadly diseases.
Quick answer
Myeloid Expands Leadership Team with Robert Hofmeister, Ph.D., as Chief Scientific Officer (February 1, 2024). Myeloid is based in United States.
- Who is the new Chief Scientific Officer at Myeloid?
- Myeloid named Robert Hofmeister Chief Scientific Officer, announced February 1, 2024.
- What did Myeloid announce on February 1, 2024?
- Myeloid Therapeutics, Inc has appointed Robert Hofmeister as Chief Scientific Officer (CSO). Dr Hofmeister brings more than 25 years of scientific leadership experience and a track record of drug discovery and early development.
- What does Myeloid do?
- Myeloid Therapeutics, Inc. is a clinical stage oncology company developing novel therapies for cancer.
- Where is Myeloid based?
- Myeloid is based in United States.
- Which similar companies made leadership changes around the same time?
- ShockWave Medical (January 29, 2024), Adverum Biotechnologies (January 29, 2024), Corcept (January 29, 2024) and TScan Therapeutics, Inc. (January 29, 2024) also announced leadership changes within 45 days of Myeloid.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Shockwave Medical Appoints Renee Gaeta as Chief Financial Officer (January 29, 2024)
- Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer (January 29, 2024)
- Corcept Appoints Roberto Vieira as President, Oncology (January 29, 2024)
- TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer (January 29, 2024)
- Mirai Medical Welcomes Former Boston Scientific Executive, David A. Pierce, as Non-Executive Director (January 23, 2024)
- Compugen Welcomes Kara Rudy as Vice President, Marketing (January 22, 2024)
Who to call at Myeloid, and when
A new leader at Myeloid brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Myeloid raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Myeloid, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Myeloid. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Myeloid changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Myeloid changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.